BRIEF-Aclaris Therapeutics completes phase 1 clinical trial of ati-50001
May 05, 2017 at 08:20 AM EDT
* Aclaris Therapeutics completes phase 1 clinical trial of ati-50001 for the treatment of alopecia universalis and alopecia totalis
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.